These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7568153)

  • 1. The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation.
    Reed M; Woelker B; Wang P; Wang Y; Anderson ME; Tegtmeyer P
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9455-9. PubMed ID: 7568153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of p53 with its consensus DNA-binding site.
    Wang Y; Schwedes JF; Parks D; Mann K; Tegtmeyer P
    Mol Cell Biol; 1995 Apr; 15(4):2157-65. PubMed ID: 7891710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 domains: structure, oligomerization, and transformation.
    Wang P; Reed M; Wang Y; Mayr G; Stenger JE; Anderson ME; Schwedes JF; Tegtmeyer P
    Mol Cell Biol; 1994 Aug; 14(8):5182-91. PubMed ID: 8035799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 domains: identification and characterization of two autonomous DNA-binding regions.
    Wang Y; Reed M; Wang P; Stenger JE; Mayr G; Anderson ME; Schwedes JF; Tegtmeyer P
    Genes Dev; 1993 Dec; 7(12B):2575-86. PubMed ID: 8276240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C-terminal domain of p53 catalyzes DNA-renaturation and strand exchange toward annealing between intact ssDNAs and toward eliminating damaged ssDNA from duplex formation through preferential recognition of damaged DNA by a duocarmycin.
    Yokote H; Nishio K; Arioka H; Kurokawa H; Fukuoka K; Fukumoto H; Ishida T; Terada T; Itakura T; Saijo N
    Mutat Res; 1998 Dec; 409(3):147-62. PubMed ID: 9875290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal interference between the sequence-specific core and nonspecific C-terminal DNA binding domains of p53: implications for regulation.
    Anderson ME; Woelker B; Reed M; Wang P; Tegtmeyer P
    Mol Cell Biol; 1997 Nov; 17(11):6255-64. PubMed ID: 9343386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction with damaged DNA induces selective proteolytic cleavage of p53 to yield 40 kDa and 35 kDa fragments competent for sequence-specific DNA binding.
    Molinari M; Okorokov AL; Milner J
    Oncogene; 1996 Nov; 13(10):2077-86. PubMed ID: 8950974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
    Bargonetti J; Manfredi JJ; Chen X; Marshak DR; Prives C
    Genes Dev; 1993 Dec; 7(12B):2565-74. PubMed ID: 8276239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization.
    Nie Y; Li HH; Bula CM; Liu X
    Mol Cell Biol; 2000 Feb; 20(3):741-8. PubMed ID: 10629029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced N- and C-terminal cleavage of p53: a core fragment of p53, generated by interaction with damaged DNA, promotes cleavage of the N-terminus of full-length p53, whereas ssDNA induces C-terminal cleavage of p53.
    Okorokov AL; Ponchel F; Milner J
    EMBO J; 1997 Oct; 16(19):6008-17. PubMed ID: 9312058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches.
    Lee S; Elenbaas B; Levine A; Griffith J
    Cell; 1995 Jun; 81(7):1013-20. PubMed ID: 7600570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmented DNA-binding activity of p53 protein encoded by a carboxyl-terminal alternatively spliced mRNA is blocked by p53 protein encoded by the regularly spliced form.
    Wolkowicz R; Peled A; Elkind NB; Rotter V
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6842-6. PubMed ID: 7624329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization.
    Shieh SY; Taya Y; Prives C
    EMBO J; 1999 Apr; 18(7):1815-23. PubMed ID: 10202145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.
    Hansen S; Lane DP; Midgley CA
    J Mol Biol; 1998 Jan; 275(4):575-88. PubMed ID: 9466932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 binds to cisplatin-damaged DNA.
    Wetzel CC; Berberich SJ
    Biochim Biophys Acta; 2001 Feb; 1517(3):392-7. PubMed ID: 11342217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic lupus erythematosus in mice, spontaneous and induced, is associated with autoimmunity to the C-terminal domain of p53 that recognizes damaged DNA.
    Herkel J; Erez-Alon N; Mimran A; Wolkowicz R; Harmelin A; Ruiz P; Rotter V; Cohen IR
    Eur J Immunol; 2000 Apr; 30(4):977-84. PubMed ID: 10760784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent and active p53 are identical in conformation.
    Ayed A; Mulder FA; Yi GS; Lu Y; Kay LE; Arrowsmith CH
    Nat Struct Biol; 2001 Sep; 8(9):756-60. PubMed ID: 11524676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 C-terminal interaction with DNA ends and gaps has opposing effect on specific DNA binding by the core.
    Zotchev SB; Protopopova M; Selivanova G
    Nucleic Acids Res; 2000 Oct; 28(20):4005-12. PubMed ID: 11024181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain.
    Bakalkin G; Selivanova G; Yakovleva T; Kiseleva E; Kashuba E; Magnusson KP; Szekely L; Klein G; Terenius L; Wiman KG
    Nucleic Acids Res; 1995 Feb; 23(3):362-9. PubMed ID: 7885831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential binding of tumor suppressor p53 to positively or negatively supercoiled DNA involves the C-terminal domain.
    Mazur SJ; Sakaguchi K; Appella E; Wang XW; Harris CC; Bohr VA
    J Mol Biol; 1999 Sep; 292(2):241-9. PubMed ID: 10493872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.